Accumulate Kotak Bank at Rs 550-490: Manghnani

Published on Fri, Oct 03, 2008 at 15:19 |  Source : CNBC-TV18

Updated at Fri, Oct 03, 2008 at 18:26  

24866 Investors following Kotak Mahindra. Share this News with them.
0
0
Share on Tumblr
Anil Manghnani, ., Modern Shares & Stock Brokers

Excerpts from Bazaar on CNBC-TV18 Watch the full show ยป

ALSO READ

Anil Manghnani of Modern Shares & Stock Brokers is of the opinion that one can accumulate Kotak Mahindra Bank between Rs 550-490.

Manghnani told CNBC-TV18, "If any fall maybe because there is only a 20% limit is to what FIIs can buy in PSU banks that's why there is not so damage in the fact that they are trying to exit pretty much everything. But still I would say any rally in this market will be led by the PSU banks but since they haven't corrected maybe the upside seems to be limited at least from the trading point of view for this month. We have gone with Kotak again; with the market making new lows. Probably in the banking sector; the private banking ICICI Bank is the only worrying; one that continues to make new lows whereas the other three whether HDFC Bank , Axis Bank and Kotak are not cracking as fast as ICICI Bank . So probably they are still safer banks to trade in. I think Rs 550-490 is a broad range to accumulate Kotak in this fall with a target of Rs 618 and in a bigger move if there is a sharp bounce to about Rs 708 with a stoploss below Rs 485."

  

More on Moneycontrol

Trending News

Business News

6 ways to backup mobile data
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com